Use of intravenous immunoglobulin in the treatment of severe cutaneous drug reactions in patients with AIDS
Authors:
- Raymond NwadiukoRNRaymond Nwadiuko
- Gildon BeallGBGildon Beall
- 1 December 1996
- journal article
- case report
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 98 (6) , 1112-1115
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpuraThe Lancet, 1993
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.Journal of Experimental Medicine, 1993
- Intravenous Immunoglobulin Therapy for Toxic Shock SyndromeJAMA, 1992
- Management of sulfadiazine allergy in patients with acquired immunodeficiency syndromeJournal of Allergy and Clinical Immunology, 1991
- ENDOTHELIAL CELL ACTIVATION AND HIGH INTERLEUKIN-1 SECRETION IN THE PATHOGENESIS OF ACUTE KAWASAKI DISEASEThe Lancet, 1989
- Modulation of in vitro synthesis of immunoglobulin and the induction of suppressor activity by therapy with intravenous immune globulinJournal of Allergy and Clinical Immunology, 1989
- Passive Protection of Rabbits Infected with Toxic Shock Syndrome-Associated Strains of Staphylococcus Aureus by Monoclonal Antibody to Toxic Shock Syndrome Toxin 1Clinical Infectious Diseases, 1989
- Improved Burn Center Survival of Patients with Toxic Epidermal Necrolysis Managed without CorticosteroidsAnnals of Surgery, 1986
- Cutaneous Reaction to Trimethoprim-Sulfamethoxazole in Patients with AIDS and Kaposi's SarcomaNew England Journal of Medicine, 1983
- Erythema Multiforme: Immune Complex Vasculitis of the Superficial Cutaneous MicrovasculatureJournal of Investigative Dermatology, 1978